Pharmacist-reviewed safety guides for adults using cannabis with SSRIs, SNRIs, and other antidepressants including Lexapro, Zoloft, Prozac, Effexor, and Wellbutrin
Check Your Specific Combination →Large-scale clinical trials on cannabis with most antidepressants remain limited. The interaction profiles below are based on known pharmacological mechanisms — specifically how CBD and THC affect the liver enzymes (CYP2D6, CYP3A4, CYP2C19) responsible for metabolizing most antidepressants — reviewed for clinical relevance by a licensed pharmacist.
| Medication Class | Common Drugs | Primary Interaction Concern | Level |
|---|---|---|---|
| SSRIs | Lexapro, Zoloft, Prozac, Paxil, Celexa | CBD inhibits CYP2D6/CYP3A4, potentially raising SSRI blood levels; serotonin pathway overlap with THC | 🟡 Moderate |
| SNRIs | Effexor, Cymbalta, Pristiq | Similar CYP enzyme competition; venlafaxine (Effexor) metabolism particularly affected by CYP2D6 inhibition | 🟡 Moderate |
| Atypical | Wellbutrin, Remeron, Trintellix | Wellbutrin lowers seizure threshold; cannabis at higher doses may compound this risk | 🟠 Watch |
| TCAs | Elavil, Pamelor, Tofranil | Tricyclics have narrow therapeutic windows; CBD-driven enzyme inhibition raises risk of elevated blood levels | 🟠 Caution |
| MAOIs | Nardil, Parnate, Marplan | MAOIs carry severe interaction risk with many substances; cannabis use should be reviewed directly with prescriber | 🔴 High Priority |
The enzyme competition between CBD and SSRI metabolism is the most clinically consistent finding in this category — relevant for anyone using full-spectrum cannabis products alongside a daily antidepressant.
Enter your antidepressant and cannabis — get a pharmacist-reviewed interaction profile in under a minute.
Open the Interaction Checker →